{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:40:01Z","timestamp":1792093201952,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170299"],"award-info":[{"award-number":["82170299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiac hypertrophy is a common structural remodeling in many cardiovascular diseases. Recently, long non-coding RNAs (LncRNAs) were found to be involved in the physiological and pathological processes of cardiac hypertrophy. In this study, we found that LncRNA KCND1 (LncKCND1) was downregulated in both transverse aortic constriction (TAC)-induced hypertrophic mouse hearts and Angiotensin II (Ang II)-induced neonatal mouse cardiomyocytes. Further analyses showed that the knockdown of LncKCND1 impaired cardiac mitochondrial function and led to hypertrophic changes in cardiomyocytes. In contrast, overexpression of LncKCND1 inhibited Ang II-induced cardiomyocyte hypertrophic changes. Importantly, enhanced expression of LncKCND1 protected the heart from TAC-induced pathological cardiac hypertrophy and improved heart function in TAC mice. Subsequent analyses involving mass spectrometry and RNA immunoprecipitation assays showed that LncKCND1 directly binds to YBX1. Furthermore, overexpression of LncKCND1 upregulated the expression level of YBX1, while silencing LncKCND1 had the opposite effect. Furthermore, YBX1 was downregulated during cardiac hypertrophy, whereas overexpression of YBX1 inhibited Ang II-induced cardiomyocyte hypertrophy. Moreover, silencing YBX1 reversed the effect of LncKCND1 on cardiomyocyte mitochondrial function and its protective role in cardiac hypertrophy, suggesting that YBX1 is a downstream target of LncKCND1 in regulating cardiac hypertrophy. In conclusion, our study provides mechanistic insights into the functioning of LncKCND1 and supports LncKCND1 as a potential therapeutic target for pathological cardiac hypertrophy.<\/jats:p>","DOI":"10.1038\/s41419-023-05852-7","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T16:02:00Z","timestamp":1685462520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1"],"prefix":"10.1038","volume":"14","author":[{"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8538-8440","authenticated-orcid":false,"given":"Lifang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-7035","authenticated-orcid":false,"given":"Haihai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-1042","authenticated-orcid":false,"given":"Tianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"5852_CR1","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.ymthe.2021.03.004","volume":"29","author":"Y Yan","year":"2021","unstructured":"Yan Y, Tang R, Li B, Cheng L, Ye S, Yang T, et al. The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy. Mol Ther. 2021;29:2253\u201367.","journal-title":"Mol Ther"},{"key":"5852_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.yjmcc.2021.06.011","volume":"159","author":"J Qin","year":"2021","unstructured":"Qin J, Guo N, Tong J, Wang Z. Function of histone methylation and acetylation modifiers in cardiac hypertrophy. J Mol Cell Cardiol. 2021;159:120\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"5852_CR3","doi-asserted-by":"publisher","first-page":"822969","DOI":"10.3389\/fcvm.2021.822969","volume":"8","author":"D Yang","year":"2021","unstructured":"Yang D, Liu HQ, Liu FY, Guo Z, An P, Wang MY, et al. Mitochondria in pathological cardiac hypertrophy research and therapy. Front Cardiovasc Med. 2021;8:822969.","journal-title":"Front Cardiovasc Med"},{"key":"5852_CR4","doi-asserted-by":"publisher","first-page":"788634","DOI":"10.3389\/fcell.2021.788634","volume":"9","author":"G Li","year":"2021","unstructured":"Li G, Li J, Shao R, Zhao J, Chen M. FUNDC1: a promising mitophagy regulator at the mitochondria-associated membrane for cardiovascular diseases. Front Cell Dev Biol. 2021;9:788634.","journal-title":"Front Cell Dev Biol"},{"key":"5852_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28358-w","volume":"13","author":"P Silva-Pinheiro","year":"2022","unstructured":"Silva-Pinheiro P, Nash PA, Van Haute L, Mutti CD, Turner K, Minczuk M. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue. Nat Commun. 2022;13:750.","journal-title":"Nat Commun"},{"key":"5852_CR6","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.1073\/pnas.1513047112","volume":"112","author":"G Santulli","year":"2015","unstructured":"Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci USA. 2015;112:11389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5852_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/HYPERTENSIONAHA.120.16752","volume":"78","author":"C Zhang","year":"2021","unstructured":"Zhang C, Niu K, Lian P, Hu Y, Shuai Z, Gao S, et al. Pathological bases and clinical application of long noncoding RNAs in cardiovascular diseases. Hypertension. 2021;78:16\u201329.","journal-title":"Hypertension"},{"key":"5852_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cvr\/cvab117","volume":"118","author":"EL Robinson","year":"2022","unstructured":"Robinson EL, Baker AH, Brittan M, McCracken I, Condorelli G, Emanueli C, et al. Dissecting the transcriptome in cardiovascular disease. Cardiovasc Res. 2022;118:1004\u201319.","journal-title":"Cardiovasc Res"},{"key":"5852_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-020-0816-0","volume":"115","author":"N Abbas","year":"2020","unstructured":"Abbas N, Perbellini F, Thum T. Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration. Basic Res Cardiol. 2020;115:52.","journal-title":"Basic Res Cardiol"},{"key":"5852_CR10","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/CIRCRESAHA.121.318992","volume":"130","author":"H Xiao","year":"2022","unstructured":"Xiao H, Zhang M, Wu H, Wu J, Hu X, Pei X, et al. CIRKIL exacerbates cardiac ischemia\/reperfusion injury by interacting with Ku70. Circ Res. 2022;130:e3\u201317.","journal-title":"Circ Res"},{"key":"5852_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20844-3","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang X, Cai B, Li Y, Jiang Y, Fu X, et al. The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia-reperfusion injury. Nat Commun. 2021;12:522.","journal-title":"Nat Commun"},{"key":"5852_CR12","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.121.056850","volume":"145","author":"H Li","year":"2022","unstructured":"Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, et al. lncExACT1 and DCHS2 regulate physiological and pathological cardiac growth. Circulation. 2022;145:1218\u201333.","journal-title":"Circulation"},{"key":"5852_CR13","doi-asserted-by":"crossref","unstructured":"Shahzadi SK, Naidoo N, Alsheikh-Ali A, Rizzo M, Rizvi AA, Santos RD, et al. Reconnoitering the role of long-noncoding RNAs in hypertrophic cardiomyopathy: a descriptive review. Int J Mol Sci. 2021;22:9378.","DOI":"10.3390\/ijms22179378"},{"key":"5852_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.119.12998","volume":"74","author":"B Cai","year":"2019","unstructured":"Cai B, Zhang Y, Zhao Y, Wang J, Li T, Zhang Y, et al. Long noncoding RNA-DACH1 (Dachshund Homolog 1) regulates cardiac function by inhibiting SERCA2a (Sarcoplasmic Reticulum Calcium ATPase 2a). Hypertension. 2019;74:833\u201342.","journal-title":"Hypertension"},{"key":"5852_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.omtn.2017.12.018","volume":"10","author":"L Lv","year":"2018","unstructured":"Lv L, Li T, Li X, Xu C, Liu Q, Jiang H, et al. The lncRNA Plscr4 controls cardiac hypertrophy by regulating miR-214. Mol Ther Nucleic Acids. 2018;10:387\u201397.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5852_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"5852_CR17","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857\u201376.","journal-title":"Circulation"},{"key":"5852_CR18","doi-asserted-by":"publisher","first-page":"H1470","DOI":"10.1152\/ajpheart.00838.2020","volume":"320","author":"KL Weeks","year":"2021","unstructured":"Weeks KL, Tham YK, Yildiz SG, Alexander Y, Donner DG, Kiriazis H, et al. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K. Am J Physiol Heart Circ Physiol. 2021;320:H1470\u201385.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5852_CR19","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.117.028274","volume":"136","author":"AA Gibb","year":"2017","unstructured":"Gibb AA, Epstein PN, Uchida S, Zheng Y, McNally LA, Obal D, et al. Exercise-induced changes in glucose metabolism promote physiological cardiac growth. Circulation. 2017;136:2144\u201357.","journal-title":"Circulation"},{"key":"5852_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1161\/CIRCULATIONAHA.120.047626","volume":"142","author":"J Omura","year":"2020","unstructured":"Omura J, Habbout K, Shimauchi T, Wu WH, Breuils-Bonnet S, Tremblay E, et al. Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension. Circulation. 2020;142:1464\u201384.","journal-title":"Circulation"},{"key":"5852_CR21","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1093\/eurheartj\/ehaa519","volume":"41","author":"J Viereck","year":"2020","unstructured":"Viereck J, Buhrke A, Foinquinos A, Chatterjee S, Kleeberger JA, Xiao K, et al. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy. Eur Heart J. 2020;41:3462\u201374.","journal-title":"Eur Heart J"},{"key":"5852_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omtn.2021.10.024","volume":"27","author":"P Shi","year":"2022","unstructured":"Shi P, Li M, Song C, Qi H, Ba L, Cao Y, et al. Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs. Mol Ther Nucleic Acids. 2022;27:16\u201336.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5852_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ymthe.2021.11.018","volume":"30","author":"J Hoepfner","year":"2022","unstructured":"Hoepfner J, Leonardy J, Lu D, Schmidt K, Hunkler HJ, Biss S, et al. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart. Mol Ther. 2022;30:1265\u201374.","journal-title":"Mol Ther"},{"key":"5852_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.121.055841","volume":"145","author":"P Wang","year":"2022","unstructured":"Wang P, Xu S, Xu J, Xin Y, Lu Y, Zhang H, et al. Elevated MCU expression by CaMKIIdeltaB limits pathological cardiac remodeling. Circulation. 2022;145:1067\u201383.","journal-title":"Circulation"},{"key":"5852_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00210-020-01953-8","volume":"394","author":"JV de Lacerda Alexandre","year":"2021","unstructured":"de Lacerda Alexandre JV, Viana YIP, David CEB, Cunha PLO, Albuquerque AC, Varela ALN, et al. Quercetin treatment increases H2O2 removal by restoration of endogenous antioxidant activity and blocks isoproterenol-induced cardiac hypertrophy. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:217\u201326.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5852_CR26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1089\/hum.2020.004","volume":"31","author":"Y Guo","year":"2020","unstructured":"Guo Y, Zhang K, Gao X, Zhou Z, Liu Z, Yang K, et al. Sustained oligomycin sensitivity conferring protein expression in cardiomyocytes protects against cardiac hypertrophy induced by pressure overload via improving mitochondrial function. Hum Gene Ther. 2020;31:1178\u201389.","journal-title":"Hum Gene Ther"},{"key":"5852_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbrc.2019.09.018","volume":"519","author":"T Ma","year":"2019","unstructured":"Ma T, Lin S, Wang B, Wang Q, Xia W, Zhang H, et al. TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction. Biochem Biophys Res Commun. 2019;519:674\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"5852_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejcb.2018.02.003","volume":"97","author":"PS Suresh","year":"2018","unstructured":"Suresh PS, Tsutsumi R, Venkatesh T. YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling. Eur J Cell Biol. 2018;97:163\u20137.","journal-title":"Eur J Cell Biol"},{"key":"5852_CR29","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1261\/rna.066738.118","volume":"24","author":"BE Jady","year":"2018","unstructured":"Jady BE, Ketele A, Kiss T. Dynamic association of human mRNP proteins with mitochondrial tRNAs in the cytosol. RNA. 2018;24:1706\u201320.","journal-title":"RNA"},{"key":"5852_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.dnarep.2009.01.021","volume":"8","author":"NC de Souza-Pinto","year":"2009","unstructured":"de Souza-Pinto NC, Mason PA, Hashiguchi K, Weissman L, Tian J, Guay D, et al. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair (Amst). 2009;8:704\u201319.","journal-title":"DNA Repair (Amst)"},{"key":"5852_CR31","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1002\/jcp.29474","volume":"235","author":"X Cao","year":"2020","unstructured":"Cao X, Zhu N, Zhang Y, Chen Y, Zhang J, Li J, et al. Y-box protein 1 promotes hypoxia\/reoxygenation- or ischemia\/reperfusion-induced cardiomyocyte apoptosis via SHP-1-dependent STAT3 inactivation. J Cell Physiol. 2020;235:8187\u201398.","journal-title":"J Cell Physiol"},{"key":"5852_CR32","first-page":"4579","volume":"19","author":"S Wang","year":"2019","unstructured":"Wang S, He F, Li Z, Hu Y, Huangfu N, Chen X. YB1 protects cardiac myocytes against H2O2-induced injury via suppression of PIAS3 mRNA and phosphorylation of STAT3. Mol Med Rep. 2019;19:4579\u201388.","journal-title":"Mol Med Rep"},{"key":"5852_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-021-02145-9","volume":"40","author":"H Zhou","year":"2021","unstructured":"Zhou H, Liu W, Zhou Y, Hong Z, Ni J, Zhang X, et al. Therapeutic inhibition of GAS6-AS1\/YBX1\/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia. J Exp Clin Cancer Res. 2021;40:353.","journal-title":"J Exp Clin Cancer Res"},{"key":"5852_CR34","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","volume":"81","author":"F Xu","year":"2021","unstructured":"Xu F, Huang M, Chen Q, Niu Y, Hu Y, Hu P, et al. LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1alpha pathway. Cancer Res. 2021;81:5678\u201391.","journal-title":"Cancer Res"},{"key":"5852_CR35","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1111\/cas.15140","volume":"112","author":"Y Li","year":"2021","unstructured":"Li Y, Gao Y, Niu X, Tang M, Li J, Song B, et al. LncRNA BASP1-AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma. Cancer Sci. 2021;112:4526\u201342.","journal-title":"Cancer Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05852-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05852-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05852-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T16:02:12Z","timestamp":1685462532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05852-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["5852"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05852-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}